Home › Macular Degeneration › Tennessee
Macular Degeneration clinical trials in Tennessee
7 studies for Macular Degeneration are looking for participants at sites in Tennessee.
Cities in Tennessee
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
- Charles Retina Institute, Germantown
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Oct 2, 2026 · NCT07440225A Study in Adults With Geographic Atrophy
- Tennessee Retina, PC, Nashville
RecruitingPhase 2
Ages 60 and older · All sexes · Updated Sep 21, 2026 · NCT07606365A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
- Tennessee Retina, PC, Nashville
- Vanderbilt Eye Institute, Nashville
RecruitingPhase 3
Ages 50 to 85 · All sexes · Updated Sep 18, 2026 · NCT06541704Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
- Vanderbilt Eye Institute, Nashville
RecruitingPhase 2
Ages 55 and older · All sexes · Updated Sep 10, 2026 · NCT066594454D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
- Tennessee Retina, Nashville
RecruitingPhase 1/2
Ages 50 and older · All sexes · Updated Aug 21, 2026 · NCT05197270A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
- Southeastern Retina Associates, Hixson
- Southeastern Retina Associates (Site 095), Johnson City
- Southeastern Retina Associates, P.C., Knoxville
- and 1 more
RecruitingPhase 2/3
Ages 50 and older · All sexes · Updated Aug 6, 2026 · NCT07496567Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
- Tennessee Retina, PC, Nashville
RecruitingPhase 3
Ages 50 and older · All sexes · Updated Apr 16, 2026 · NCT07064759From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.